Patent · US Expired

Use of avian antibodies

US6537550B1 · kind B1 · utility

3Cited by
15References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 20, 1999
Grant dateMar 25, 2003
Priority date
Expiry dateSep 20, 2019

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to use of avian antibodies and/or antigen binding fragments thereof, for the production of a drug for treatment and/or prevention of respiratory tract infection. The drug is administered through local application at the oral cavity and/or pharynx.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.